AEMD

Aethlon Medical Inc

5.29

Nov 13 • 3:59 PM ET -0.29 (-5.20%)

5.29

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Healthcare Medical Devices USA Nano NASD

Nov 12, 6:45 PMAethlon Medical says merger-related cuts and pending transaction will limit enrollment in its Phase 1 oncology study

Peers: CTSO ICU CERS NUWE OM VNRX HAE NEPH RMTI DXR

Scroll to Statements

Index	-
Market Cap	8.48M
Enterprise Value	2.21M
Income	-8.07M
Sales	0.00M
Book/sh	3.77
Cash/sh	4.05
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	9
IPO	May 11, 1994

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.40
P/C	1.31
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	5.21
Current Ratio	5.21
Debt/Eq	0.04
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-24.88
EPS next Y	-1.91
EPS next Q	-1.71
EPS this Y	87.76%
EPS next Y	70.59%
EPS next 5Y	76.48%
EPS past 3/5Y	71.71% 54.12%
Sales past 3/5Y	- -
EPS Y/Y TTM	90.69%
Sales Y/Y TTM	-
EPS Q/Q	86.11%
Sales Q/Q	-
Earnings	Nov 12 AMC
EPS/Sales Surpr.	3.70% -

Insider Own	6.98%
Insider Trans	0.00%
Inst Own	7.44%
Inst Trans	5.87%
ROA	-110.11%
ROE	-136.76%
ROIC	-133.29%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-1.65%
SMA50	3.21%
SMA200	-27.95%
Trades

Shs Outstand	1.61M
Shs Float	1.49M
Short Float	2.90%
Short Ratio	0.02
Short Interest	0.04M
52W High	25.66 -79.38%
52W Low	1.41 275.18%
Volatility	5.79% 6.91%
ATR (14)	0.39
RSI (14)	48.02
Beta	1.23
Rel Volume	0.01
Avg Volume	2.52M
Volume	26,490

Perf Week	-3.29%
Perf Month	0.38%
Perf Quarter	80.24%
Perf Half Y	-49.62%
Perf YTD	-61.81%
Perf Year	-77.68%
Perf 3Y	-99.20%
Perf 5Y	-99.96%
Perf 10Y	-100.00%
Recom	3.00
Target Price	13.25
Prev Close	5.58
Price	5.29
Change %	-5.20%

Consensus

Hold

Avg. Price Target

$13.25

Implied Upside

+150.5%

Analysts1incl. previous ratings

Rating Distribution0 Buy · 1 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jul 07, 2025	Resumed	HH.C. Wainwright	Neutral	$1.50	-71.6%

Nov-12-26 04:30PM	Aethlon Medical Reports Second Quarter Fiscal 2027 Results and Provides Corporate Update (PR Newswire) -5.20%
Sep-21-26 02:30PM	Are PRTH, MG, AEMD Obtaining Fair Deals for their Shareholders? (PR Newswire)
Sep-17-26 08:36AM	Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger (InvestorsHub) +374.13%
07:09AM	North Immunology joins biotech reverse merger boom with Aethlon deal (BioPharma Dive)
06:30AM	Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis (PR Newswire)
04:15PM	Loading…
Aug-13-26 04:15PM	Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program (PR Newswire)
Aug-05-26 08:01AM	Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 (PR Newswire) -7.67%
Jul-13-26 08:01AM	Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier (PR Newswire) -5.51%
Jul-06-26 09:25AM	Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules (PR Newswire) +11.25%
Jun-26-26 08:01AM	Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier (PR Newswire)
07:00AM	From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak (Newsfile)
Jun-17-26 12:18PM	Aethlon Medical advances Hemopurifier study as final trial cohort nears completion (Proactive)
Jun-16-26 09:00PM	Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call Highlights: Strategic Advances Amid Financial ... (GuruFocus.com)
Jun-10-26 04:15PM	Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update (PR Newswire) -5.94%
Jun-02-26 08:01AM	Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 (PR Newswire) -8.30%
08:01AM	Loading…
May-21-26 08:01AM	Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness (PR Newswire)
Mar-24-26 10:30AM	Advancements in Novel Immunotherapeutics in The Oncology Battle (Newsfile) -6.09%
08:01AM	Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review (PR Newswire)
Mar-13-26 12:02PM	Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives (NewMediaWire) +12.72%
Mar-12-26 08:01AM	Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities (PR Newswire)
Feb-23-26 08:01AM	Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 (PR Newswire)
Feb-15-26 08:01PM	Aethlon Medical Inc (AEMD) Q3 2026 Earnings Call Highlights: Progress in Oncology Trials and ... (GuruFocus.com)
Feb-12-26 04:15PM	Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update (PR Newswire) -5.26%
Feb-04-26 08:01AM	Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026 (PR Newswire)
Dec-05-25 09:15AM	Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million (PR Newswire) -8.19%
Dec-02-25 08:01AM	Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs (PR Newswire) +14.87%
Nov-12-25 04:15PM	Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update (PR Newswire) +12.86%
Nov-07-25 08:01AM	Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025 (PR Newswire)
Oct-08-25 07:00AM	Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates (Newsfile)
Oct-07-25 08:01AM	Aethlon Medical's Hemopurifier shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial (PR Newswire) -5.82%
09:25AM	Loading…
Sep-05-25 09:25AM	Aethlon Medical announces pricing of $4.5M common stock, warrant offering (TipRanks)
Sep-04-25 09:15AM	Aethlon Medical Announces Pricing of $4.5 Million Public Offering (PR Newswire) -45.62%
07:00AM	Innovation and IP in Medtech Stocks - How Patents Build Leaders (Newsfile)
Sep-03-25 08:01AM	Aethlon Medical Announces Issuance of Hemopurifier Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC) (PR Newswire) -17.68%
Aug-21-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +97.30%
Aug-15-25 05:01PM	Aethlon Medical Inc (AEMD) Q1 2026 Earnings Call Highlights: Strategic Focus on Australian ... (GuruFocus.com)
Aug-13-25 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update (PR Newswire)
Aug-05-25 08:01AM	Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025 (PR Newswire)
Jul-15-25 08:01AM	Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort (PR Newswire)
Jun-26-25 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update (PR Newswire) +23.57% -35.57%
Jun-20-25 08:01AM	Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025 (PR Newswire) -9.20%
Jun-18-25 08:01AM	Aethlon Medical Treats Second Patient in Australian Hemopurifier Cancer Trial (PR Newswire)
Jun-16-25 07:00AM	Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream (GlobeNewswire)
Jun-09-25 08:01AM	Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes (PR Newswire) -12.85%
May-14-25 08:01AM	Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Platelet-Derived Extracellular Vesicles from Plasma (PR Newswire)
Mar-26-25 07:00AM	Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now (GlobeNewswire)
Mar-25-25 07:00AM	Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now (GlobeNewswire)
Mar-10-25 08:01AM	Aethlon Medical Publishes Preclinical Data on the Hemopurifier in Transplant Immunology Journal (PR Newswire) -5.54%
Feb-19-25 06:00AM	Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now (GlobeNewswire)
Feb-13-25 01:08PM	Q3 2025 Aethlon Medical Inc Earnings Call (Thomson Reuters StreetEvents) -5.51%
08:01AM	Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025 (PR Newswire)
Feb-12-25 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update (PR Newswire)
Feb-05-25 08:01AM	Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025 (PR Newswire) +8.57%
Jan-30-25 10:00AM	Aethlon Medical treats first subject with Hemopurifier device in Australia (Medical Device Network)
Jan-29-25 08:01AM	Aethlon Medical Treats First Patient in Australian Hemopurifier Cancer Trial (PR Newswire) +18.96%
Dec-20-24 08:01AM	Aethlon Medical Provides Update on the Ability of Its Hemopurifier to Capture H5N1 Bird Flu (PR Newswire) +33.83%
Dec-04-24 07:00AM	Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now (GlobeNewswire)
Dec-03-24 07:00AM	Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now (GlobeNewswire)
Nov-14-24 08:00AM	Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally (Newsfile)
02:14AM	Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... (GuruFocus.com)
Nov-13-24 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update (PR Newswire)
Nov-12-24 08:00AM	Innovative Medical Technology Advances with First Patient Enrollments (Newsfile) -7.84%
Nov-11-24 11:18AM	Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer (Medical Device Network) +5.98%
08:01AM	Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in Australia (PR Newswire)
Nov-06-24 08:01AM	Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024 (PR Newswire)
Oct-30-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now (GlobeNewswire)
Oct-29-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now (GlobeNewswire)
Oct-09-24 06:26PM	Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ... (GuruFocus.com)
Oct-08-24 08:01AM	Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit (PR Newswire) -7.03%
Sep-25-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 2 on September 26 (GlobeNewswire)
Sep-24-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now (GlobeNewswire)
Sep-20-24 08:35AM	Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing (GlobeNewswire) -8.21%
Sep-19-24 10:00AM	Immunotherapy Clinical Trials - A New Approach to Treating Cancer (Newsfile) +8.82%
08:01AM	Aethlon Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India (PR Newswire)
Sep-17-24 08:01AM	Aethlon Medical to Present at Virtual Investor Conferences in September (PR Newswire)
03:30AM	Innovation Driving Cancer's Solid Tumors Market (Newsfile)
Sep-16-24 12:07PM	Life Sciences Virtual Investor Forum Agenda Announced for September 19th (GlobeNewswire)
08:01AM	Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial (PR Newswire)
Sep-13-24 08:35AM	Aethlon Medical to Present at the Life Sciences Investor Forum September 19th (GlobeNewswire)
Aug-27-24 08:01AM	Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys (PR Newswire) -7.36%
Aug-14-24 04:15PM	Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update (PR Newswire) +15.93% -16.86%
Aug-13-24 06:53AM	Aethlon Medical receives ethics committee approval for trial of cancer treatment (Clinical Trials Arena) +6.22%
Aug-12-24 09:01AM	The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors (Newsfile)
08:01AM	Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier Cancer Trial (PR Newswire)
Aug-06-24 09:12AM	Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024 (PR Newswire) +11.54%
Jun-28-24 08:03AM	Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2024 Earnings Call Transcript (Insider Monkey) -13.81%
Jun-27-24 08:52PM	AEMD Stock Earnings: Aethlon Medical Beats EPS for Q4 2024 (InvestorPlace)
04:15PM	Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update (PR Newswire)
Jun-21-24 08:01AM	Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 (PR Newswire)
Jun-20-24 07:00AM	What's Next in Treatments for Cancer Patients with Solid Tumors? (Newsfile) -12.59%
Jun-18-24 08:01AM	Aethlon Medical Receives Ethics Committee Approval for Hemopurifier Cancer Trial (PR Newswire) +5.37%
Jun-07-24 08:00AM	The Hunt for Virus Treatments Continues Post Covid-19 (Newsfile) +6.51%
Jun-06-24 08:12AM	Why Is Aethlon Medical (AEMD) Stock Up 82% Today? (InvestorPlace) +25.42%
07:38AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jun-03-24 09:05AM	Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID (Newsfile) +5.26%
08:01AM	Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies (PR Newswire)
May-15-24 01:34PM	Top Midday Decliners (MT Newswires) -52.95%
09:15AM	Aethlon Medical Announces Pricing of $4.7 Million Public Offering (PR Newswire)

Show Previous News

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.

CEOMr. James B. Frakes M.B.A.

Chief Medical OfficerDr. Steven P. LaRosa M.D.

VP & ControllerMs. Michele Bombardiere

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

AEMD

Aethlon Medical Inc

Upgrade your Finviz experience

All the Features.
Half the Price.